MedPath

Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 2

Not Applicable
Completed
Conditions
Healthy
Registration Number
NCT02447783
Lead Sponsor
University of California, Davis
Brief Summary

Flavanols are plant-derived compounds commonly present in the human diet. Examples of flavanol-containing foods and beverages are apples, chocolate, tea, wine, berries, pomegranate and nuts. The consumption of flavanol-containing foods and beverages has been associated with improvements in cardiovascular health. In this study, the investigators hope to learn more about the effects of long term consumptions of cocoa flavanols on blood pressure, platelet function and other metabolic parameters in healthy humans. This study is a continuation of a previous study investigating the consumptions of increasing amounts of cocoa flavanols on blood pressure, platelet function and other metabolic parameters in healthy humans

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • 30-55 years old
  • A normal blood chemistry and liver function
  • BMI < 30 kg/m2
  • previously consumed cocoa and peanut products, with no adverse reactions
Exclusion Criteria
  • A history of cardiovascular disease, stroke, hypertension, renal, hepatic, or thyroid disease, GI tract disorders, previous GI surgery, metabolic syndrome, diabetes, taking cholesterol-lowering medication, hormone replacement therapy, antioxidant supplements, on aspirin therapy or taking anticoagulants, or on a medically prescribed diet.
  • Allergies to nuts, cocoa and chocolate products
  • Vegetarian, Vegan, food faddists, individuals using non-traditional diets, on a weight loss diet or using herbal dietary supplements

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in blood pressureBaseline (day 0) and 6,12 and 14 weeks after intervention

Blood pressure will be measured using standard techniques.

Secondary Outcome Measures
NameTimeMethod
Change in platelet functionBaseline and 6, 12 and 14 weeks after intervention

Platelet function will be determined using the PFA-100® analyzer (Dade Behring International, Miami, FL) with collagen-epinephrine (CEPI)- and collagen-ADP (CADP) stimulation.

Change in 24 h ambulatory blood pressureBaseline (day 0) and 12 weeks after intervention

24 h ambulatory blood pressure will be measured using standard techniques.

Change in metabolic parameters in bloodBaseline (day 0) and 6, 12 and 14 weeks after intervention

Metabolic parameters determined in blood included: comprehensive metabolic panel, liver panel and cell blood counting.

Trial Locations

Locations (1)

Ragle Human Nutrition Research Center, Department of Nutrition at UC Davis

🇺🇸

Davis, California, United States

Ragle Human Nutrition Research Center, Department of Nutrition at UC Davis
🇺🇸Davis, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.